Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Xiaomi's shares rose sharply after its chief executive and founder Lei Jun bought the company's shares, which have been weighed by concerns of rising memory-chip prices and electric-vehicle production ...

President Donald Trump is working on a healthcare plan that could address expiring Obamacare subsidies, the issue that ...

The approval rating for Japanese Prime Minister Sanae Takaichi's Cabinet was essentially unchanged from when it launched, at 72%, according to a nationwide poll conducted by The Yomiuri Shimbun from ...

U.S. stocks were gearing up for a short but potentially strong trading week with Thanksgiving now just around the corner.

Meta reportedly is considering using Alphabet’s custom chips for its data centers. Nvidia and AMD shares are falling on the ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Shares of Sandisk rose on plans to join the S&P 500 index, just months after its spinoff to become an independent public company. The stock rose 6.9% to $242.62 in after-hours trading on Monday.

Shares of Woodward rose after the company's fiscal fourth-quarter results and full-year sales outlook came in ahead of Wall Street's expectations, helped by growing demand for its aerospace offerings.

Fluence Energy said 85% of the backlog included in its fiscal-year outlook was already secured. The stock rose 13% to $17.80 in after-hours trading Monday. Keysight Technologies logged higher revenue ...

Shares of Amentum advanced after the company said fiscal fourth-quarter revenue jumped ahead of expectations. The stock rose 10% to $27.89 in after-hours trading Monday. Through the close the stock ...

Bristol Myers Squibb received approval from the European Commission to bring its cancer-fighting drug Breyanzi to market. The pharmaceutical company said Monday it had received a greenlight for the ...